These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 19560538)

  • 1. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel.
    Lacoeuille F; Hindre F; Moal F; Roux J; Passirani C; Couturier O; Cales P; Le Jeune JJ; Lamprecht A; Benoit JP
    Int J Pharm; 2007 Nov; 344(1-2):143-9. PubMed ID: 17646066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition.
    Lamprecht A; Benoit JP
    J Control Release; 2006 May; 112(2):208-13. PubMed ID: 16574265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells.
    Roger E; Lagarce F; Garcion E; Benoit JP
    Eur J Pharm Sci; 2010 Aug; 40(5):422-9. PubMed ID: 20438839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanocapsules for intracellular drug delivery of anticancer drugs.
    Lacoeuille F; Garcion E; Benoit JP; Lamprecht A
    J Nanosci Nanotechnol; 2007 Dec; 7(12):4612-7. PubMed ID: 18283853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
    Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
    Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms.
    Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP
    Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adaptation of lipid nanocapsule formulations for blood administration in animals.
    Hureaux J; Lagarce F; Gagnadoux F; Clavreul A; Benoit JP; Urban T
    Int J Pharm; 2009 Sep; 379(2):266-9. PubMed ID: 19467305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.
    Allard E; Passirani C; Garcion E; Pigeon P; Vessières A; Jaouen G; Benoit JP
    J Control Release; 2008 Sep; 130(2):146-53. PubMed ID: 18582507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
    Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
    Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.
    Ho EA; Vassileva V; Allen C; Piquette-Miller M
    J Control Release; 2005 May; 104(1):181-91. PubMed ID: 15866344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
    Lundberg BB
    Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi trigger responsive, surface active lipid nanovesicle aerosols for improved efficacy of paclitaxel in lung cancer.
    Joshi N; Kaviratna A; Banerjee R
    Integr Biol (Camb); 2013 Jan; 5(1):239-48. PubMed ID: 22911380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
    Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
    Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and characterization of polyphenol-loaded lipid nanocapsules.
    Barras A; Mezzetti A; Richard A; Lazzaroni S; Roux S; Melnyk P; Betbeder D; Monfilliette-Dupont N
    Int J Pharm; 2009 Sep; 379(2):270-7. PubMed ID: 19501139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gastrointestinal stability of lipid nanocapsules.
    Roger E; Lagarce F; Benoit JP
    Int J Pharm; 2009 Sep; 379(2):260-5. PubMed ID: 19524655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance.
    Ji X; Gao Y; Chen L; Zhang Z; Deng Y; Li Y
    Int J Pharm; 2012 Jan; 422(1-2):390-7. PubMed ID: 22001531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro drug release mechanism from lipid nanocapsules (LNC).
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Int J Pharm; 2010 May; 390(2):208-13. PubMed ID: 20149853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocopheryl succinate-based lipid nanospheres for paclitaxel delivery: preparation, characters, and in vitro release kinetics.
    Shi K; Jiang Y; Zhang M; Wang Y; Cui F
    Drug Deliv; 2010 Jan; 17(1):1-10. PubMed ID: 19941405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.